Next Article in Journal
A Systematic Review and Meta-Analysis of B Vitamin Supplementation on Depressive Symptoms, Anxiety, and Stress: Effects on Healthy and ‘At-Risk’ Individuals
Next Article in Special Issue
Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans
Previous Article in Journal
Accounting for the Nutritional Context to Correctly Interpret Results from Studies of Exercise and Sedentary Behavior
Previous Article in Special Issue
Dietary Polyacetylenic Oxylipins Falcarinol and Falcarindiol Prevent Inflammation and Colorectal Neoplastic Transformation: A Mechanistic and Dose-Response Study in A Rat Model
 
 
Review
Peer-Review Record

Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects

Nutrients 2019, 11(9), 2231; https://doi.org/10.3390/nu11092231
by Baltasar Mayo 1,2,*, Lucía Vázquez 1,2 and Ana Belén Flórez 1,2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Nutrients 2019, 11(9), 2231; https://doi.org/10.3390/nu11092231
Submission received: 22 August 2019 / Revised: 5 September 2019 / Accepted: 11 September 2019 / Published: 16 September 2019
(This article belongs to the Special Issue Dietary Bioactive Compounds and Human Health and Disease)

Round 1

Reviewer 1 Report

The review is clearly written and well organized.

 

Line 2: does not sound to me “a bacterial a metabolite” better a bacterial metabolite.

Line 62: delete –

Line 199-201: please re-write the sentence, it  is not clear enough

Line 213: is also surprisingly that… instead of Also surprising is the fact 


Author Response

Please, see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

This is an interesting review of equol with extensive referencing and, for the most part, a balanced perspective. There are some suggestions and corrections.

Line 201.  "quantification" is not the best word.  Should use "quantify". Lines 221 - 224.  It is not possible that the incidence of CVD and other disorders is 1/8 seen in the West.  It is plausible that there is a delay in CVD, for example, but CVD and cancer are still responsible for the majority of the deaths. Line 236.  The reference should be #106, not #105. Lines 269-270.  Again, the statement that in the Orient that CVD "incidence" is 12-13% of the West seems implausible.  Perhaps one needs to define "incidence". Lines 283-285.  It is also not plausible that any dietary intervention would increase bone mineral density by 50%.  Drugs are not able to do this.  Maintaining bone density or few percentage increase over time are the best outcomes to be expected. Lines 327 -372.  This section on "Mechanisms" needs some perspective.  These are largely in vitro studies using very high molar concentrations of isoflavones compared to physiological quantities.  The authors should be careful to point this out either by each study or overall. Line 358.  There is a typo for reference #182. Line 377.  Use of the word "powerful" is not justified as there is little to no in vivo evidence for this. Line 650.  Typo "atherosclerosis" 

Author Response

Please, see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

The authors have carefully addressed the concerns of the reviewer and have further done additional editing that has enhanced the manuscript.  The only point to me made is that in the References section all references are numbered twice (in other words, for example reference 4 reads "4.  4. Aguiar......" - which seems unusual.

Back to TopTop